Investigation of using DLEU7-AS1 expression as a potential predictor of AML outcome
(A–C) Kaplan–Meier estimate for the OS of the Chinese cohort of patients in the whole-cohort (A), non-M3 (B) and (C) CN-AML group. (D) Validation of the prognostic value of using DLEU7-AS1 expression in three independent cohorts of patients with AML (GSE12417, n=79; GSE37642, n=136; TCGA microarray, n=183). Survival analyzes were performed on the DLEU7-AS1low and DLEU7-AS1high groups and P-values were calculated using the Kaplan–Meier method.